Re-appointment of Mr. Ashok Hiremath (DIN: 00349345) as Non-Executive Independent Director of the Company, subject to the approval of shareholders of the Company
DAICHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On May 16, 2025, the Board of Dai-Ichi Karkaria approved multiple governance items. Mr. Ashok Hiremath (DIN: 00349345), founder of Astec LifeSciences and a 40+ year veteran of the chemical industry, has been re-appointed as Non-Executive Independent Director for a fresh 5-year term from September 8, 2025 to September 7, 2030, subject to shareholder approval. Mr. Tajendra Gupta, formerly Senior VP at Total Energies and ex-Managing Director of a Nigerian oil company, has been appointed to Senior Management as Business Head effective May 16, 2025. M/s Vinod Kothari & Company, Practicing Company Secretaries, has been appointed as Secretarial Auditor for 5 years (FY2025-26 to FY2029-30), also subject to shareholder nod. The Board also cleared adopting a new Memorandum and Articles of Association aligned with the Companies Act, 2013, including flexibility to explore new business lines beyond the current chemical focus.
These are largely routine governance housekeeping items and should not materially move the stock. The re-appointment provides continuity on the board, while the new Business Head brings deep oil & gas downstream experience that may hint at strategic diversification beyond specialty chemicals.